JOHNSON & JOHNSON SG&A Expense 2007-2025 | JNJ
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is JOHNSON & JOHNSON's current sg&a expense?
JOHNSON & JOHNSON (JNJ) annual sg&a expense for 2025 was $23.68B, a 3.53% increase from 2024. JOHNSON & JOHNSON sg&a expense for the quarter ending December 28, 2025 was $6.75B.
What was JOHNSON & JOHNSON's sg&a expense in 2024?
JOHNSON & JOHNSON annual sg&a expense for 2024 was $22.87B, a 6.31% increase from 2023.
What was JOHNSON & JOHNSON's sg&a expense in 2023?
JOHNSON & JOHNSON annual sg&a expense for 2023 was $21.51B, a 6.93% increase from 2022.
What is JOHNSON & JOHNSON's 4-year sg&a expense CAGR?
JOHNSON & JOHNSON sg&a expense grew at a compound annual growth rate (CAGR) of 1.76% from FY2021 to FY2025, going from $22.08B to $23.68B over 4 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+1.3%
FY2019
$22.18B
→
FY2025
$23.68B
07081011121314161718192122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $23.68B | +3.5% | 10-K |
| FY2024 | $22.87B | +6.3% | 10-K |
| FY2023 | $21.51B | +6.9% | 10-K |
| FY2022 | $20.12B | -8.9% | 10-K |
| FY2021 | $22.08B | -0.4% | 10-K |
| FY2019 | $22.18B | -1.6% | 10-K |
| FY2018 | $22.54B | +4.7% | 10-K |
| FY2017 | $21.52B | +1.5% | 10-K |
| FY2016 | $21.20B | -3.4% | 10-K |
| FY2014 | $21.95B | +0.6% | 10-K |
| FY2013 | $21.83B | +4.6% | 10-K |
| FY2012 | $20.87B | +7.4% | 10-K |
| FY2011 | $19.42B | -1.9% | 10-K |
| FY2010 | $19.80B | -7.9% | 10-K |
| FY2008 | $21.49B | +5.1% | 10-K |
| FY2007 | $20.45B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →